Please login to the form below

Not currently logged in


This page shows the latest clinical news and features for those working in and with pharma, biotech and healthcare.

Merck to acquire Pandion Therapeutics for $1.85bn

Merck to acquire Pandion Therapeutics for $1.85bn

The investigational candidate completed a phase 1a clinical trial earlier this year, achieving its primary objective of safety and tolerability. ... In just a few years, we have taken that mission from idea to clinical proof of mechanism with PT101, our

Latest news

More from news
Approximately 192 fully matching, plus 4,601 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 20 fully matching, plus 667 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 525 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 134 fully matching, plus 580 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...